Literature DB >> 14632705

Progression to clinically diagnosed and treated diabetes from impaired glucose tolerance and impaired fasting glycaemia.

Q Qiao1, J Lindström, T T Valle, J Tuomilehto.   

Abstract

AIMS: To evaluate the risk of diabetes in subjects with impaired fasting glycemia (IFG) as compared with impaired glucose tolerance (IGT) and normal glucose tolerance.
METHODS: Men (1223) and women (1370) aged 45-64 years and free of diabetes at baseline were followed-up for 10 years, with 26 737 person years accumulated. The incident diabetic cases were identified through the national Drug Register and the Hospital Discharge Register.
RESULTS: During the 10 years of follow-up, 53 (4.3%) men and 47 (3.4%) women developed diabetes. IFG alone defined 22 (15.5/1000 person years) diabetic cases, which was higher than for subjects with normal fasting glucose. Subjects with isolated IGT identified an additional 34 cases (155% more) which could not be defined by IFG alone. The area under the ROC curve was larger for 2-h glucose (0.77, 95% CI 0.72-0.82) than for fasting glucose (0.65, 0.58-0.71). The multivariate adjusted Cox hazard ratio was higher for isolated IGT (3.9, 95% CI 2.4-6.2) than for isolated IFG (2.3, 0.9-5.7) as compared with subjects with neither IFG nor IGT.
CONCLUSION: Both IFG and IGT are risk predictors for diabetes, but IGT defines a much larger target population for prevention.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14632705     DOI: 10.1111/j.1464-5491.2003.01054.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  14 in total

1.  Progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screening programme in general practice: the ADDITION Study, Denmark.

Authors:  S S Rasmussen; C Glümer; A Sandbaek; T Lauritzen; K Borch-Johnsen
Journal:  Diabetologia       Date:  2006-12-02       Impact factor: 10.122

2.  Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C.

Authors:  Hirokazu Takahashi; Toshihiko Mizuta; Yuichiro Eguchi; Yasunori Kawaguchi; Takuya Kuwashiro; Satoshi Oeda; Hiroshi Isoda; Noriko Oza; Shinji Iwane; Kenichi Izumi; Keizou Anzai; Iwata Ozaki; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2011-02-18       Impact factor: 7.527

3.  Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark.

Authors:  S S Rasmussen; C Glümer; A Sandbaek; T Lauritzen; K Borch-Johnsen
Journal:  Diabetologia       Date:  2007-12-05       Impact factor: 10.122

4.  Comparison of fasting glucose with post-load glucose values and glycated hemoglobin for prediction of type 2 diabetes: the Isfahan diabetes prevention study.

Authors:  Mohsen Janghorbani; Masoud Amini
Journal:  Rev Diabet Stud       Date:  2009-08-10

5.  Impaired fasting glucose prevalence in two nationwide cohorts of obese children and adolescents.

Authors:  E Hagman; T Reinehr; J Kowalski; A Ekbom; C Marcus; R W Holl
Journal:  Int J Obes (Lond)       Date:  2013-07-05       Impact factor: 5.095

6.  Risk equations for the development of worsened glucose status and type 2 diabetes mellitus in a Swedish intervention program.

Authors:  Anne Neumann; Margareta Norberg; Olaf Schoffer; Fredrik Norström; Ingegerd Johansson; Stefanie J Klug; Lars Lindholm
Journal:  BMC Public Health       Date:  2013-10-26       Impact factor: 3.295

7.  The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group.

Authors:  N G Forouhi; B Balkau; K Borch-Johnsen; J Dekker; C Glumer; Q Qiao; A Spijkerman; R Stolk; A Tabac; N J Wareham
Journal:  Diabetologia       Date:  2006-03-09       Impact factor: 10.122

8.  Progression to impaired glucose regulation and diabetes in the population-based Inter99 study.

Authors:  Susanne Engberg; Dorte Vistisen; Cathrine Lau; Charlotte Glümer; Torben Jørgensen; Oluf Pedersen; Knut Borch-Johnsen
Journal:  Diabetes Care       Date:  2008-12-29       Impact factor: 19.112

9.  Cost-effectiveness of alternative thresholds of the fasting plasma glucose test to identify the target population for type 2 diabetes prevention in adults aged ≥45 years.

Authors:  Xiaohui Zhuo; Ping Zhang; Henry S Kahn; Edward W Gregg
Journal:  Diabetes Care       Date:  2013-10-17       Impact factor: 19.112

10.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.